Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank25
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P25
Within normal range
vs 3Y Ago
-2.9x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -68.40% |
| 2024 | -269.75% |
| 2023 | 196.16% |
| 2022 | 23.40% |
| 2021 | 0.00% |